The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.
暂无分享,去创建一个
Thomas D. Wu | P. Carnevali | M. Kennemer | K. Pant | R. Gentleman | D. Ballinger | Zhaoshi Jiang | S. Seshagiri | Z. Modrušan | A. Jubb | Zemin Zhang | J. Stinson | Y. Guan | P. Haverty | Jinfeng Liu | S. Jhunjhunwala | Stephanie Johnson | H. Stern | F. D. de Sauvage | J. Diao | William Lee | S. Yeung | Weilan Ye | S. Kapadia | Peter M. Haverty | Jeremy Stinson
[1] Critical Roles of Nuclear Receptor Response Elements in Replication of Hepatitis B Virus , 2001, Journal of Virology.
[2] A. Sparks,et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient , 2010, Nature.
[3] Steven J. M. Jones,et al. Circos: an information aesthetic for comparative genomics. , 2009, Genome research.
[4] S. Poppema,et al. The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin‐driven sprouting neovascularization , 2008, Hepatology.
[5] M. Bouchard,et al. Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. , 2011, Cancer letters.
[6] R. Jordan,et al. Molecular viral oncology of hepatocellular carcinoma , 2003, Oncogene.
[7] Robert B. Hartlage,et al. This PDF file includes: Materials and Methods , 2009 .
[8] M. Sterneck,et al. Clinical reactivation after liver transplantation with an unusual minor strain of hepatitis B virus in an occult carrier , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[9] Natarajan Ganesan,et al. Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon , 2010, Cancer Cell International.
[10] P. Kleihues,et al. AXIN1 mutations but not deletions in cerebellar medulloblastomas , 2003, Oncogene.
[11] Seunghee Lee,et al. Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors. , 2008, Molecular endocrinology.
[12] E. Birney,et al. A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.
[13] T. Okanoue,et al. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas , 2005, Gut.
[14] Mulyanto,et al. Analysis of the full‐length genomes of novel hepatitis B virus subgenotypes C11 and C12 in Papua, Indonesia , 2011, Journal of medical virology.
[15] Takehide Asano,et al. Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed‐lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma , 2008, Human mutation.
[16] W. Huber,et al. which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .
[17] Serban Nacu,et al. Fast and SNP-tolerant detection of complex variants and splicing in short reads , 2010, Bioinform..
[18] M. Chen,et al. Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation , 1993, Molecular and cellular biology.
[19] T. Okanoue,et al. Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging , 2001, Oncogene.
[20] Yoshiki Murakami,et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene , 2003, Oncogene.
[21] F. Zoulim,et al. Hepatitis B virus induced hepatocellular carcinoma. , 2009, Cancer letters.
[22] R. Roeder,et al. A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4 , 2009, Proceedings of the National Academy of Sciences.
[23] S. Gabriel,et al. Advances in understanding cancer genomes through second-generation sequencing , 2010, Nature Reviews Genetics.
[24] Hidenori Ojima,et al. High-resolution characterization of a hepatocellular carcinoma genome , 2011, Nature Genetics.
[25] Tom Royce,et al. A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.
[26] Ronald A. DePinho,et al. Hepatocellular carcinoma pathogenesis: from genes to environment , 2006, Nature Reviews Cancer.
[27] Robert W. Williams,et al. The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival , 2008, Clinical & Experimental Metastasis.
[28] A. Dejean,et al. Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[29] C. Bréchot,et al. Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). , 2000, Seminars in cancer biology.
[30] I. Tomlinson,et al. Colorectal cancer and genetic alterations in the Wnt pathway , 2006, Oncogene.
[31] D. Lavanchy,et al. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures , 2004, Journal of viral hepatitis.
[32] N. Carter,et al. Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.
[33] P Michielsen,et al. Viral hepatitis B and hepatocellular carcinoma. , 2011, Acta gastro-enterologica Belgica.
[34] S. Boyault,et al. Differential effects of inactivated Axin1 and activated β-catenin mutations in human hepatocellular carcinomas , 2007, Oncogene.
[35] S. Litwin,et al. Clonal Expansion of Normal-Appearing Human Hepatocytes during Chronic Hepatitis B Virus Infection , 2010, Journal of Virology.
[36] A. Raney,et al. Characterization of the hepatitis B virus major surface antigen promoter hepatocyte nuclear factor 3 binding site. , 1997, The Journal of general virology.